Multimorbidity patterns in the working age population with the top 10% medical cost from exhaustive insurance claims data of Japan Health Insurance Association
- PMID: 37768909
- PMCID: PMC10538783
- DOI: 10.1371/journal.pone.0291554
Multimorbidity patterns in the working age population with the top 10% medical cost from exhaustive insurance claims data of Japan Health Insurance Association
Abstract
Although the economic burden of multimorbidity is a growing global challenge, the contribution of multimorbidity in patients with high medical expenses remains unclear. We aimed to clarify multimorbidity patterns that have a large impact on medical costs in the Japanese population. We conducted a cross-sectional study using health insurance claims data provided by the Japan Health Insurance Association. Latent class analysis (LCA) was used to identify multimorbidity patterns in 1,698,902 patients who had the top 10% of total medical costs in 2015. The present parameters of the LCA model included 68 disease labels that were frequent among this population. Moreover, subgroup analysis was performed using a generalized linear model (GLM) to assess the factors influencing annual medical cost and 5-year mortality. As a result of obtaining 30 latent classes, the kidney disease class required the most expensive cost per capita, while the highest portion (28.6%) of the total medical cost was spent on metabolic syndrome (MetS) classes, which were characterized by hypertension, dyslipidemia, and type 2 diabetes. GLM applied to patients with MetS classes showed that cardiovascular diseases or complex conditions, including malignancies, were powerful determinants of medical cost and mortality. MetS was classified into 7 classes based on real-world data and accounts for a large portion of the total medical costs. MetS classes with cardiovascular diseases or complex conditions, including malignancies, have a significant impact on medical costs and mortality.
Copyright: © 2023 Nishida et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
Fuminori Katsukawa received funding from the Japan Health Insurance Association. Yuki Nishida was paid from funding from the Japan Health Insurance Association for 1 year from April 2021 to March 2022. The other authors declare no competing interests. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Figures



Similar articles
-
Social determinants of multimorbidity in Jamaica: application of latent class analysis in a cross-sectional study.BMC Public Health. 2021 Jun 23;21(1):1197. doi: 10.1186/s12889-021-11225-6. BMC Public Health. 2021. PMID: 34162349 Free PMC article.
-
Multimorbidity patterns and their relationship to mortality in the US older adult population.PLoS One. 2021 Jan 20;16(1):e0245053. doi: 10.1371/journal.pone.0245053. eCollection 2021. PLoS One. 2021. PMID: 33471812 Free PMC article.
-
Costs of multimorbidity: a systematic review and meta-analyses.BMC Med. 2022 Jul 19;20(1):234. doi: 10.1186/s12916-022-02427-9. BMC Med. 2022. PMID: 35850686 Free PMC article.
-
Prevalence and patterns of multimorbidity in the Jamaican population: A comparative analysis of latent variable models.PLoS One. 2020 Jul 23;15(7):e0236034. doi: 10.1371/journal.pone.0236034. eCollection 2020. PLoS One. 2020. PMID: 32702046 Free PMC article.
-
Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.Pharmacoeconomics. 2004;22(6):389-411. doi: 10.2165/00019053-200422060-00005. Pharmacoeconomics. 2004. PMID: 15099124 Review.
Cited by
-
Development and evaluation of an integrated multispecialty clinic for people with multiple long-term conditions.Future Healthc J. 2025 Mar 4;12(2):100235. doi: 10.1016/j.fhj.2025.100235. eCollection 2025 Jun. Future Healthc J. 2025. PMID: 40242005 Free PMC article.
-
Impact of lifestyle behaviors on the development of lifestyle diseases: A retrospective cohort study.PLoS One. 2025 Jul 29;20(7):e0327505. doi: 10.1371/journal.pone.0327505. eCollection 2025. PLoS One. 2025. PMID: 40729338 Free PMC article.
-
Spatial Analysis of patterns of Multimorbidity in the Thai Cohort Study Using Latent Class Analysis.J Epidemiol Glob Health. 2025 Feb 12;15(1):24. doi: 10.1007/s44197-025-00352-7. J Epidemiol Glob Health. 2025. PMID: 39937408 Free PMC article.
References
-
- Ministry of Health, Labour and Welfare (Japan). https://www.mhlw.go.jp/english/org/policy/p34-35.html.
-
- Kasajima M, Eggleston K, Kusaka S, Matsui H, Tanaka T, Son BK, et al.. Projecting prevalence of frailty and dementia and the economic cost of care in Japan from 2016 to 2043: a microsimulation modelling study. Lancet Public Health. 2022;7: e458–e468. doi: 10.1016/S2468-2667(22)00044-5 - DOI - PMC - PubMed
-
- Bloom DE, Cafiero ET, Jané-Llopis E, Abrahams-Gessel S, Bloom LR, Fathima S, et al.. The Global Economic Burden of Noncommunicable Diseases. Geneva: World Economic Forum; 2011.
-
- Cohen SB, Uberoi N. Differentials in the Concentration in the Level of Health Expenditures across Population Subgroups in the U.S., 2010. Statistical Brief (Medical Expenditure Panel Survey (US)). Rockville (MD): Agency for Healthcare Research and Quality (US); 2001. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials